Global Spatial Genomics and Transcriptomics Market is Projected to Reach $2,173.0 Million

According to a new market intelligence report by BIS Research titled ‘Global Spatial Genomics and Transcriptomics Market − Analysis and Forecast, 2020-20230’, As per BIS Research analysis, the global spatial genomics and transcriptomics market is projected to reach $2,173.0 million by 2030 from $269.6 million in 2020, at a CAGR of 23.20% during the forecast period, 2020-2030.

BIS Research Report: https://bisresearch.com/industry-report/spatial-genomics-transcriptomics-market.html

Growth in this market is expected to be driven by the rising incidence of genetic disorders such as cancer and neurological disorders inciting the development of high-throughput diagnostics. This growing prevalence incites the development of rapid diagnostic assays, technological advancements in sequencing technology, and significant external funding for executing R&D exercise. However, there are significant challenges that are restraining the market growth, such as a shortage of computational analysis tools and high capital required for infrastructure and development of spatial technology-based solutions.

Request for Sample Report: https://bisresearch.com/requestsample?id=1018&type=download

The BIS Research report on the global spatial genomics and transcriptomics market segments the market on the basis of product type (kits and assays, instruments, software and services), application (diagnostics, translational research, drug discovery and development, single cell analysis, cell biology and others), end user (academic and research institutions, biopharmaceutical and biotechnological companies, contract research organizations and other end users), and region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World).

About BIS Research:

BIS Research is a global B2B market intelligence and advisory firm focusing on those emerging technological trends which are likely to disrupt the dynamics of the market.

With over 150 market research reports published annually, BIS Research focuses on high technology verticals such as 3D Printing, Advanced Materials and Chemicals, Aerospace and Defense, Automotive, Healthcare, Electronics and Semiconductors, Robotics and UAV, and other emerging technologies.

Our in-depth market intelligence reports focus on the market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.

What distinguishes BIS Research from the rest of the players is that we don’t simply provide data but also complement it with valuable insights and actionable inputs for the success of our clients.

Comments

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing microbiome therapeutics market is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...

Ligase Market Opportunities, Strategies, Share, Segmentation, In-depth Analysis 2032

The global ligase market is progressing rapidly with a significant increase in the research and development activities pertaining to a wide range of ligase product for disease detection, accentuating their criticality in healthcare. Ligase enzyme has a critical role in the molecular diagnostics approach, as it ensures the safe and effective application of targeted therapeutics. Most of the players in the global ligase market offer products encompassing the ligation kits and enzymes. The global ligase market is projected to reach $651.4 million by 2032 from $371.2 million in 2021, at a CAGR of 5.29% during the forecast period 2022-2032. The growth in the global ligase market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases on a global level, rising awareness of enzyme based diagnostic testing and significant number of funding for executing research and development. Impact Several techniques are employed in ...

PD-1/PDL-1 Inhibitor Market Growth Prospects, Emerging Trends and Forecast to 2032

PD-1/PDL-1 inhibitors are immune-therapeutic agents used in the treatment of various cancer indications, mostly in the advanced stages. PD-1/PDL-1 inhibitors are monoclonal antibodies majorly of IgG1 and IgG4 types to be administered to patients via injection The current market already has seven approved products in the U.S. and a large number of research activities are currently undergoing in this segment generating interest of commercial as well as academic research institutions. In the current period of precision medicine and providing targeted treatment, identification of target patient has become very important as well as complicated. With the emergence of diagnostic test identifying predictive biomarkers, the selection and administration of targeted treatment has become comparativlely conveninent and efficient. PD-1/PDL-1 inhibitors market are majorly indicated for the treatment of advanced cases of different cancer indications. The PD-1/PDL-1 inibitor treatment has ...

Market Research Reports

Search This Blog